E2 (Endovascular Engineering)
Homepage - Endovascular Engineering
Menlo Park, United States · Founded 2019 · $137.0M raised
- Headquarters
- Menlo Park, California
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- endovascularengineering.com
- Total Funding
- $137.0M
- Last Round
- $15.0M Series AApr 2026
- Rounds
- 3
About
E2 (Endovascular Engineering) is a commercial-stage medical device company developing next-generation clot removal technologies for venous thromboembolism. Its Hēlo PE Thrombectomy System uses combined high-speed agitation and aspiration to treat pulmonary embolism and deep vein thrombosis in a single pass with minimal procedural complexity.
Summary
E2 (Endovascular Engineering) is a Healthcare company based in Menlo Park, United States, founded in 2019. It has raised $137.0M in total across 3 rounds, most recently a $15.0M Series A round in Apr 2026.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
operates in the healthcare industry focusing on biotechnology business
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...